Canada· CA-DIN-02442183
VARIZIG
A varicella/zoster immunoglobulin product containing varicella zoster immunoglobulin (human), registered in Canada by KI BIOPHARMA LLC. The same ATC class is registered in 4 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Varicella/zoster immunoglobulin is registered in 4 of 19 countries.
Countries holding a registration under ATC J06BB03 (varicella/zoster immunoglobulin), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 3 of them publish a price we can compare per daily dose
Varicella/zoster immunoglobulin · ATC J06BB03
4 / 19 countries
- Canada
- Czechiaprice
- Norwayprice
- Switzerlandprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- VARICELLA ZOSTER IMMUNOGLOBULIN (HUMAN)
- Manufacturer
- KI BIOPHARMA LLC
- Country
- Canada (CA)
- ATC code
- J06BB03
- ATC class
- Varicella/zoster immunoglobulin
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Varicella/zoster immunoglobulin in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandVaritect CP, Lösung zur intravenösen InjektionBiotest (Schweiz) AG
- United KingdomLiberim Z 250mg solution for injection vialsScottish National Blood Transfusion Service
- CzechiaVARITECT CP
- GermanyVaritect CpBiotest Pharma Gmbh
- NorwayVarizigKI BioPharma
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Austria · Varitect Cp
- Germany · Varitect Cp
- United Kingdom (Northern Ireland) · Human Varicella-Zoster Immunoglobulin Bio Products Laboratory
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cea3fdee-9d19-47fd-93db-8916a3b84fc3 GET /v1/drugs/cea3fdee-9d19-47fd-93db-8916a3b84fc3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02442183",
"form": "SOLUTION",
"class": "Human",
"routes": [
"INTRAMUSCULAR",
"INTRAVENOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "J06BB03",
"schedule": [
"Schedule D"
],
"drug_code": "92654",
"strengths": [
"125 UNIT"
],
"ahfs_class": null,
"substances": [
"VARICELLA ZOSTER IMMUNOGLOBULIN (HUMAN)"
],
"product_categorization": null
}See everything about varicella/zoster immunoglobulin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.